SG
Insider
Scott T Garrett
DirectorScott T Garrett (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in HCW Biologics Inc. (HCWB). Across 1 priced purchase filing, the average 21-session return was -66.4% from execution and -57.6% from disclosure (delay-adjusted; derived). The largest single filing was $250K of HCWB (177,936 sh × $1.41, as filed), executed May 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-66.4%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-57.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
5d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$250K
shares × price, as filed
Last traded
May 22
Filed May 27
Volume by month
Buys $490K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
HCWBRecent filings
HCWBPURCHASE
HCW Biologics Inc.
View filing →
$250K177,936 sh × $1.41
Exec May 22
Filed May 27 · 7:25 PM ET HCWBPURCHASE HCW Biologics Inc. View filing → $100K
13,423 sh × $7.45
Exec May 16 2025
Filed May 20 2025 · 5:30 PM ET HCWBPURCHASE HCW Biologics Inc. View filing → $140K
5,385 sh × $26.00
Exec May 8 2025
Filed May 9 2025 · 5:30 PM ET